PLSH Stock Chart & Stats
$0.10
$0.02(20.00%)
At close: 4:00 PM EDT
$0.10
$0.02(20.00%)
Day’s Range― - ―
52-Week Range$0.02 - $0.20
Previous CloseN/A
Volume4.90K
Average Volume (3M)2.30K
Market Cap
$6.80M
Enterprise Value$855.36K
Total Cash (Recent Filing)$40.83K
Total Debt (Recent Filing)$186.69K
Price to Earnings (P/E)―
Beta2.40
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding67,990,910
10 Day Avg. Volume1,599
30 Day Avg. Volume2,296
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)0.55
Price to Sales (P/S)3.27
P/FCF Ratio4.82
Enterprise Value/Market Cap0.13
Enterprise Value/Revenue3.24
Enterprise Value/Gross Profit-0.53
Enterprise Value/Ebitda-0.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Panacea Life Sciences Holdings Inc News
PLSH FAQ
What was Panacea Life Sciences Holdings Inc’s price range in the past 12 months?
Panacea Life Sciences Holdings Inc lowest stock price was $0.02 and its highest was $0.20 in the past 12 months.
What is Panacea Life Sciences Holdings Inc’s market cap?
Panacea Life Sciences Holdings Inc’s market cap is $6.80M.
When is Panacea Life Sciences Holdings Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Panacea Life Sciences Holdings Inc’s earnings last quarter?
Panacea Life Sciences Holdings Inc released its earnings results on Nov 19, 2020. The company reported -$1.01 earnings per share for the quarter.
Is Panacea Life Sciences Holdings Inc overvalued?
According to Wall Street analysts Panacea Life Sciences Holdings Inc’s price is currently Overvalued.
Does Panacea Life Sciences Holdings Inc pay dividends?
Panacea Life Sciences Holdings Inc does not currently pay dividends.
What is Panacea Life Sciences Holdings Inc’s EPS estimate?
Panacea Life Sciences Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Panacea Life Sciences Holdings Inc have?
Panacea Life Sciences Holdings Inc has 67,990,910 shares outstanding.
What happened to Panacea Life Sciences Holdings Inc’s price movement after its last earnings report?
Panacea Life Sciences Holdings Inc reported an EPS of -$1.01 in its last earnings report. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Panacea Life Sciences Holdings Inc?
Currently, no hedge funds are holding shares in PLSH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Panacea Life Sciences Holdings Inc
Panacea Life Sciences Holdings, Inc. operates as an integrated research and production firm, specializing in cannabinoid and nutraceutical products across the entire supply chain, from sourcing to final sale. Its core mission is to develop and deliver natural, pharmaceutical-grade alternatives for both human and pet consumption. The company's diverse product range encompasses items such as softgels, edible gummies, liquid tinctures, sublingual tablets, and a variety of cosmetic and topical applications. In addition to these offerings, the company is involved in the personal protective equipment (PPE) market, importing and distributing hand sanitizers and masks. Panacea Life Sciences also provides white-label and contract manufacturing services to other cannabinoid companies, sells raw materials, and manages tolling arrangements. Established in 2008, the company is headquartered in Greenwood Village, Colorado.